Technical Analysis for ONCS - OncoSec Medical Incorporated

Grade Last Price % Change Price Change
grade F 0.4498 -5.11% -0.02
ONCS closed down 5.11 percent on Friday, May 17, 2019, on 75 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ONCS trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze Ended Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -5.11%
180 Bearish Setup Bearish Swing Setup -5.11%
Reversal New Lows Setup Bearish Swing Setup -5.11%

Older signals for ONCS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
OncoSec Medical Incorporated, a hybrid device and gene therapy biotechnology company, designs, develops, and commercializes medical approaches principally immunotherapy for the treatment of solid tumors in the United States. Its clinical programs include three Phase II clinical trials to assess the ImmunoPulse technology in patients with melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma. It has a collaboration agreement with Heat Biologics, Inc. to evaluate the combination of immunotherapy platforms. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated is headquartered in San Diego, California.
Medicine Biotechnology Biology Immunotherapy Solid Tumors Cancer Treatments Gene Therapy Virotherapy Genetic Engineering Melanoma Cutaneous T Cell Lymphoma Heat Biologics Merkel Cell Carcinoma
Is ONCS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.96
52 Week Low 0.42
Average Volume 531,666
200-Day Moving Average 0.949
50-Day Moving Average 0.5632
20-Day Moving Average 0.542
10-Day Moving Average 0.5161
Average True Range 0.045
ADX 19.77
+DI 9.7231
-DI 24.5226
Chandelier Exit (Long, 3 ATRs ) 0.615
Chandelier Exit (Short, 3 ATRs ) 0.577
Upper Bollinger Band 0.6115
Lower Bollinger Band 0.4725
Percent B (%b) -0.16
BandWidth 25.645757
MACD Line -0.0273
MACD Signal Line -0.0178
MACD Histogram -0.0095
Fundamentals Value
Market Cap 9.52 Million
Num Shares 21.2 Million
EPS -1.14
Price-to-Earnings (P/E) Ratio -0.39
Price-to-Sales 0.00
Price-to-Book 1.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.55
Resistance 3 (R3) 0.56 0.54 0.53
Resistance 2 (R2) 0.54 0.51 0.53 0.53
Resistance 1 (R1) 0.49 0.49 0.48 0.48 0.52
Pivot Point 0.47 0.47 0.46 0.46 0.47
Support 1 (S1) 0.42 0.44 0.41 0.42 0.38
Support 2 (S2) 0.40 0.43 0.39 0.37
Support 3 (S3) 0.36 0.40 0.36
Support 4 (S4) 0.35